Team

we are a group of researchers INTERESTED in ischemia-reperfusion injury & ex-vivo machine perfusion in human kidney- and liver transplantation

Georg Lurje, M.D.

Professor of Surgery, Head of Liver- and Abdominal Transplant Surgery, Heidelberg University Hospital with a special research focus on ex-vivo machine perfusion in human liver- and kidney transplantation. Principal investigator of the HOPE ECD-DBD, HOPE-NMP and NMB-DBD machine perfusion clinical trials.

Deniz Uluk, M.d.

HPB- & Transplant Fellow, Heidelberg University Hospital with a special research focus on ex-vivo machine perfusion, body composition and clinical outcomes in HPB- and transplantation. Local coordinator of the HOPE-NMP and NMP-DBD trials.

FREDERIK SCHLIEPHAKE, M.D.

Surgical Resident, Heidelberg University Hospital with a special research focus on organ reconditioning and ex-vivo machine perfusion. Co-investigator of the HOPE-NMP and NMP-DBD trials.

Isabella Lurje, M.D.

Post-doc Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin with a special research focus on liver immunology and molecular mechanisms of ex-vivo machine perfusion and genomic profiling.

Malte Gerrit Lehnert

Final-year medical student, Charité Universitätsmedizin Berlin, with a special research focus on organ reconditioning and ex-vivo machine perfusion of kidney- and liver-allografts.

Dina Biegel

Final-year medical student, Charité Universitätsmedizin Berlin, with a special research focus on organ reconditioning and ex-vivo machine perfusion of kidney- and liver-allografts.


Medicine is a science of uncertainty and an art of probability.

William Osler